Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Harvey Vaughan John Adams has worked on the following 49 EPO patent applications which have been published in the last five years:

EP12075069

Novel restriction endonucleases, DNA encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity

IPC classification:
C12N 9/22, C12N 15/55
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12075067

Novel restriction endonucleases, DNA encoding these endonucleases and methods for identyfing new endonucleases with the same or varied specificity

IPC classification:
C12N 9/22, C12N 15/55
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12189626

Stepped cannula

IPC classification:
A61B 17/34, A61M 25/06
Applicant:
Genzyme Corporation
Applicant:
The Regents of the University of California
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11853462

OPTIMIZATION OF MULTIGENE ANALYSIS OF TUMOR SAMPLES

IPC classification:
C12Q 1/68, C40B 30/10
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11842041

BENZODIAZEPINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
A61K 31/55
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12192841

Method of treating autoimmune disease with mesenchymal stem cells

IPC classification:
A61K 35/28, A61P 3/10, C12N 5/0775
Applicant:
Genzyme Corporation
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12192839

Method of treating autoimmune disease with mesenchymal stem cells

IPC classification:
A61K 35/28, A61K 38/13, A61P 3/10, C12N 5/0775
Applicant:
Genzyme Corporation
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12804528

INHIBITORS OF T-CELL ACTIVATION

IPC classification:
A61K 39/395
Applicant:
Genzyme Corporation
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11861101

NPP1 FUSION PROTEINS

IPC classification:
A61P 3/10, A61P 9/10, C07K 19/00, C12N 15/62, C12N 15/63, C12N 15/86
Agent:
Deborah Mary Hart, Kilburn & Strode LLP
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13173895

Intraventricular enzyme delivery for lysosomal storage diseases

IPC classification:
A61K 38/46
Applicant:
Genzyme Corporation
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12173124

Method for producing plant seed containing endophytic micro-organisms

IPC classification:
A01C 1/06, A01N 25/00, A01N 63/04, C05F 11/08, C12N 1/04, C12R 1/01
Applicant:
AIT Austrian Institute of Technology GmbH
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Sonn & Partner
Status:
EXAMINATION IN PROGRESS
EP12755254

METHODS AND COMPOSITIONS FOR TREATING DEPRESSION USING CYCLOBENZAPRINE

IPC classification:
A61K 31/137, A61K 31/55, A61K 45/06, A61P 25/24
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14150948

Drug loaded polymeric nanoparticles and methods of making and using same

IPC classification:
A61K 9/16, A61K 31/337, A61K 33/24, A61K 47/34, A61K 47/48, C08G 63/668, C08G 63/672
Agent:
Jennifer Lucy Harris, Kilburn & Strode LLP
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Pfizer Inc
Status:
EXAMINATION REQUESTED
EP13188102

Antibody purification

IPC classification:
C07K 1/18, C07K 16/00
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13188107

Antibody purification

IPC classification:
C07K 1/18, C07K 16/00
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13877986

HUMAN ANTIBODIES THAT BIND HUMAN TNF-ALPHA AND METHODS OF PREPARING THE SAME

IPC classification:
A61K 39/00, C07K 1/18, C07K 16/24, C12N 5/10, G01N 33/68
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
APPLICATION WITHDRAWN
EP11715322

ANTI-NERVE GROWTH FACTOR (NGF) ANTIBODY COMPOSITIONS

IPC classification:
A61K 39/395, C07K 16/18, C07K 16/22, C07K 16/28
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785752

MODULATED LYSINE VARIANT SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME

IPC classification:
C07K 16/00, C07K 16/28, C12N 5/00
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13786072

LOW ACIDIC SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME

IPC classification:
C07K 16/24
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Graham James Lock, Fry Heath & Spence LLP
Status:
GRANT OF PATENT INTENDED
EP14186885

Methods for treating psoriasis

IPC classification:
A01N 37/18, A61K 38/00
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12742453

CENTRIFUGE ROTOR FOR SEPARATION AND PROCESSING OF COMPLEX FLUIDS

IPC classification:
B04B 5/02, G01N 27/07
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14195388

Engineered nucleic acids and methods of use thereof

IPC classification:
C07H 21/02, C12N 5/07
Applicant:
Moderna Therapeutics, Inc.
Agent:
Hoffmann Eitle PartmbB
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13712650

METHODS TO CONTROL PROTEIN HETEROGENEITY

IPC classification:
C12N 5/10
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP11804475

SYSTEMS FOR FACTOR VIII PROCESSING AND METHODS THEREOF

IPC classification:
C07K 14/755, C12N 9/60, C12N 9/64, C12N 15/00, C12P 21/04, C12P 21/06
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11738539

PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME

IPC classification:
A61K 47/42, C07K 16/46, C07K 19/00
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11738538

CHIMERIC CLOTTING FACTORS

IPC classification:
A61K 38/36, A61K 38/48, C12N 9/96
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13162010

PC5 as a factor IX propeptide processing enzyme

IPC classification:
C07K 14/745, C12N 9/64
Applicant:
BIOGEN IDEC HEMOPHILIA INC.
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15154238

Nucleic acids and proteins from streptococcus group A & B

IPC classification:
C07K 14/315
Applicant:
Novartis Vaccines and Diagnostics Srl
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15152668

Isolation and purification of antibodies using Protein A affinity chromatography

IPC classification:
C07K 1/16, C07K 16/00, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15165128

HUMAN ANTIBODIES THAT BIND HUMAN TNFALPHA

IPC classification:
A61K 39/395, C07K 16/24, C12N 1/21, C12N 5/10, C12N 15/09, C12N 15/13, C12N 15/64, G01N 33/68
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15165134

HUMAN ANTIBODIES THAT BIND HUMAN TNFALPHA

IPC classification:
A61K 39/395, C07K 16/24, C12N 1/21, C12N 5/10, C12N 15/09, C12N 15/13, C12N 15/64, G01N 33/68
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15165138

HUMAN ANTIBODIES THAT BIND HUMAN TNFALPHA

IPC classification:
A61K 39/395, C07K 16/24, C12N 1/21, C12N 5/10, C12N 15/09, C12N 15/13, C12N 15/64, G01N 33/68
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15165123

HUMAN ANTIBODIES THAT BIND HUMAN TNFALPHA

IPC classification:
A61K 39/395, C07K 16/24, C12N 1/21, C12N 5/10, C12N 15/09, C12N 15/13, C12N 15/64, G01N 33/68
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15165133

METHODS OF ADMINISTERING ANTI-TNFALPHA ANTIBODIES

IPC classification:
A61K 31/519, A61K 39/395, A61P 19/02, A61P 37/06, C07K 16/24
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11833232

PROCESSES FOR PURIFICATION OF PROTEINS

IPC classification:
B01D 15/08, C07K 1/36
Applicant:
AbbVie Inc
Applicant:
AbbVie Bahamas Limited
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Micaela Nadia Modiano, Modiano & Partners
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15169378

Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion

IPC classification:
A61K 9/14, A61K 9/20, A61K 31/425
Applicant:
AbbVie Inc
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15157149

Treatment of TNF alpha related disorders

IPC classification:
A61K 39/395, C07K 16/24
Applicant:
AbbVie Biotechnology Ltd
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12746845

METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY

IPC classification:
A61K 38/46, A61P 3/06
Agent:
Kristina Victoria Joy Cornish, Kilburn & Strode LLP
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13785756

PURIFICATION OF PROTEINS USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY

IPC classification:
A61K 39/395, C07K 1/16, C07K 1/18, C07K 1/20, C07K 1/22, C07K 1/34, C07K 1/36, C07K 16/24
Applicant:
AbbVie Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14200334

ISOLATED RECOMBINANT HUMAN N-GLYCOSYLATED LYSOSOMAL ACID LIPASE

IPC classification:
A01K 67/027, A61K 31/135, A61K 31/194, A61K 31/366, A61K 31/397, A61K 38/38, A61K 38/46, A61P 3/06, C12N 9/18, C12N 9/20
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14715521

COMPOSITIONS AND METHODS OF ALTERING CHOLESTEROL LEVELS

IPC classification:
A61K 31/70, A61K 48/00, C07K 14/705, C12N 15/12, C12N 15/63, C12N 15/67
Applicant:
Moderna Therapeutics, Inc.
Agent:
Hoffmann Eitle PartmbB
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP15178740

CLOTTING FACTOR-FC CHIMERIC PROTEINS TO TREAT HEMOPHILIA

IPC classification:
A61K 38/36, A61K 39/00, A61K 39/395, A61K 45/06, A61K 47/48, C07K 14/745, C07K 16/18, C12N 9/64, C12P 21/08
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13163182

AAV virions with decreased immunoreactivity and uses therefor

IPC classification:
C07K 1/00, C07K 14/00, C07K 14/015, C07K 17/00, C12N 15/00, C12N 15/09, C12N 15/63, C12N 15/70, C12N 15/74, C12N 15/864
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11758644

USE OF LYSOSOMAL ACID LIPASE FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS

IPC classification:
A61K 31/135, A61K 31/366, A61K 31/397, A61K 38/46, A61P 3/06
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13163168

AAV virions with decreased immunoreactivity and uses therefor

IPC classification:
C07K 1/00, C07K 14/00, C07K 14/015, C07K 17/00, C12N 15/00, C12N 15/09, C12N 15/63, C12N 15/70, C12N 15/74, C12N 15/864
Applicant:
Genzyme Corporation
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11841746

PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT

IPC classification:
A61K 31/50
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16157001

FORMULATION OF BORONIC ACID COMPOUNDS

IPC classification:
A61K 31/69, A61K 38/05, A61P 29/00, A61P 35/00, C07F 5/02, C07F 5/04, C07K 5/078
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11761225

PURIFICATION OF ANTIBODIES USING SIMULATED MOVING BED CHROMATOGRAPHY

IPC classification:
B01D 15/18, C07K 1/16, C07K 16/00
Applicant:
AbbVie Inc
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Agent:
Micaela Nadia Modiano, Modiano & Partners
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP16198524

ADALIMUMAB FOR USE IN THERAPY OF RHEUMATOID ARTHRITIS

IPC classification:
A61K 31/519, A61K 39/395, A61P 19/02, A61P 37/06, C07K 16/24
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
The application has been published

Please Sign in to use this feature